05/12/2025
NICC (Non-Invasive ChromosomesCheck) is a safe and highly accurate non-invasive prenatal test (NIPT) that analyzes cell-free fetal DNA from a small maternal blood sample to screen for chromosomal abnormalities as early as 10 weeks of pregnancy.
Powered by advanced NGS and fetal DNA enrichment technology, NICC enables clinicians to offer expecting parents reliable insights into their baby’s genetic health, without any risk to the mother or baby.
Here’s how NICC fits into the recommended prenatal care pathway, based on ACOG and ACMG guidelines.
✨1. Beyond “High Risk”: Why All Pregnant Individuals Should Be Offered NIPT✨
✅ NICC: Screens for the most common chromosomal conditions across all pregnancies
✅ NICC Extended: Adds clinically significant microdeletion / microduplication syndromes for deeper insight
📌 ACOG Guidance:
- Maternal age should not determine access to NIPT.
- All pregnant individuals, regardless of being